What's Behind Adaptive Biotechnologies' Q1 Earnings Miss
Investors have probably pretty much forgotten that Adaptive Biotechnologies (NASDAQ: ADPT) shares sank more than 40% earlier this year. That's because the stock made a remarkable rebound and was up nearly 19% year to date as of Tuesday.
But Adaptive's momentum could be derailed at least somewhat going forward. The biotech announced its first-quarter results after the market closed on Tuesday. Here are the highlights from Adaptive's Q1 update.
Image source: Getty Images.
Source Fool.com
